Qiagen Partners with U Penn Team to Identify Molecular Signatures for Gene Doping | GenomeWeb
NEW YORK (GenomeWeb News) – Qiagen said today that it is partnering with researchers from the University of Pennsylvania to develop molecular tests to detect gene doping in athletes.
 
In the project, supported by the World Anti-Doping Agency and Qiagen, the U Penn team plans to climb Mount Everest with live mice. The researchers plan to use tissue and blood samples from these mice to identify a molecular signature for altitude-induced hypoxia, or oxygen deficiency.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.